TABLE OF CONTENTS
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS (Page No. - 68)
4.1 HIGH-THROUGHPUT SCREENING (HTS) MARKET OVERVIEW
4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY OFFERING AND COUNTRY (2023)
4.3 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
4.4 HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY END USER, 2023
4.5 HIGH-THROUGHPUT SCREENING (HTS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 72)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing adoption of open innovation models
5.2.1.2 Rising government funding and venture capital investments
5.2.1.3 Increasing R&D spending
5.2.1.4 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 High cost of using HTS instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing adoption of HTS technologies in emerging markets
5.2.3.2 Growing research on novel therapeutics
5.2.3.3 Drug repurposing
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled operators
5.2.4.2 Complexities in data management, assay development, and analysis
5.3 INDUSTRY TRENDS
5.3.1 ADOPTION OF PHENOTYPIC SCREENING
5.3.2 AUTOMATION AND AI INTEGRATION
5.3.3 RISE OF CRISPR TECHNOLOGY
5.3.4 INTEGRATION OF SINGLE-CELL ANALYSIS TECHNOLOGIES
5.3.5 REGULATORY CONSIDERATIONS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 High-content screening/analysis
5.4.1.2 Label-free detection (surface plasmon resonance)
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Microfluidics, organ-on-a-chip (OOC), and lab-on-a-chip (LOC)
5.4.2.2 Mass spectrometry (MS)
5.4.2.3 Flow cytometry
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Fragment-based drug discovery
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.6 PRICING ANALYSIS
5.7 VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
5.9.1 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS
5.9.2 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
5.9.3 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS
5.9.4 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR SPECTROMETERS
5.11.2 IMPORT DATA FOR MASS SPECTROMETERS
5.11.3 EXPORT DATA FOR SPECTROMETERS
5.11.4 EXPORT DATA FOR MASS SPECTROMETERS
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY LANDSCAPE
5.12.1.1 US
5.12.1.2 Europe
5.12.1.3 Emerging markets
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PORTER’S FIVE FORCES ANALYSIS
5.13.1 INTENSITY OF COMPETITIVE RIVALRY
5.13.2 BARGAINING POWER OF SUPPLIERS
5.13.3 BARGAINING POWER OF BUYERS
5.13.4 THREAT OF SUBSTITUTES
5.13.5 THREAT OF NEW ENTRANTS
5.14 KEY CONFERENCES & EVENTS, 2024–2025
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS OF HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.15.2 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES
5.15.3 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES, BY END USER
6 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING (Page No. - 117)
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 REAGENTS & ASSAY KITS
6.2.1.1 Growing applications of HTS in drug discovery and life science research to support demand for consumables
6.2.2 LABORATORY CONSUMABLES
6.2.2.1 Growing automation in high-throughput screening to propel market growth
6.3 INSTRUMENTS
6.3.1 LIQUID HANDLING SYSTEMS
6.3.1.1 Ongoing technological advancements and automation to support market growth
6.3.2 DETECTION SYSTEMS
6.3.2.1 High demand for high-throughput and sensitive detection systems to propel market
6.3.3 IMAGING INSTRUMENTS
6.3.3.1 Advancements in high-content imaging systems to boost market
6.3.4 OTHER INSTRUMENTS
6.4 SERVICES
6.4.1 INCREASING ASSAY COMPLEXITIES AND GROWING NEED FOR COST-EFFECTIVE AND SPECIALIZED HTS EXPERTISE TO BOOST DEMAND
6.5 SOFTWARE
6.5.1 ONGOING INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE TOOLS TO DRIVE MARKET
7 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION (Page No. - 155)
7.1 INTRODUCTION
7.2 DRUG DISCOVERY
7.2.1 GROWING DEMAND FOR MORE EFFECTIVE METHODS TO IDENTIFY NEW DRUG CANDIDATES TO SUPPORT MARKET GROWTH
7.3 BIOCHEMICAL SCREENING
7.3.1 GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO BOOST MARKET GROWTH
7.4 LIFE SCIENCE RESEARCH
7.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH TO CONTRIBUTE TO MARKET GROWTH
7.5 OTHER APPLICATIONS
8 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY (Page No. - 172)
8.1 INTRODUCTION
8.2 CELL-BASED ASSAYS
8.2.1 2D CELL CULTURES
8.2.1.1 Cost-effectiveness of 2D cell cultures to promote market growth
8.2.2 3D CELL CULTURES
8.2.2.1 Scaffold-based technology
8.2.2.1.1 Hydrogels
8.2.2.1.1.1 Animal-derived hydrogels
8.2.2.1.1.1.1 Matrigel
8.2.2.1.1.1.1.1 Increasing applications of Matrigel in drug discovery and life science research to support market growth
8.2.2.1.1.1.2 Collagen
8.2.2.1.1.1.2.1 Growing demand for personalized medicines to support market growth
8.2.2.1.1.2 Synthetic hydrogels
8.2.2.1.1.2.1 Better consistency and low risk of contamination to increase adoption and drive growth
8.2.2.1.1.3 Alginate/Agarose
8.2.2.1.1.3.1 Ability of alginate to enhance accuracy and relevance to propel adoption
8.2.2.1.2 Inert matrices/Solid scaffolds
8.2.2.1.2.1 Lack of native-like microenvironment and other disadvantages to restrain growth
8.2.2.1.3 Micropatterned surfaces
8.2.2.1.3.1 Greater enzyme levels and drug reactivity to support adoption
8.2.2.2 Scaffold-free technology
8.2.2.2.1 Ultra-low-binding plates
8.2.2.2.1.1 Demand for high-quality, low-background assays to boost market
8.2.2.2.2 Hanging-drop plates
8.2.2.2.2.1 Cost-effectiveness to boost adoption among end users
8.2.2.2.3 Other scaffold-free technologies
8.2.3 REPORTER-BASED ASSAYS
8.2.3.1 Growing applications of gene expression to support growth
8.2.4 PERFUSION CELL CULTURES
8.2.4.1 Ongoing research to develop perfusion cell culture technology for drug discovery to support adoption
8.3 LAB-ON-A-CHIP
8.3.1 INCREASING APPLICATIONS OF LAB-ON-A-CHIP TECHNOLOGY FOR HTS AND PRECISION MEDICINE DEVELOPMENT TO SUPPORT MARKET GROWTH
8.4 LABEL-FREE TECHNOLOGY
8.4.1 ABILITY TO CONDUCT LABEL-FREE INVESTIGATION OF BIOMOLECULAR INTERACTIONS TO PROPEL ADOPTION
9 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER (Page No. - 246)
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 GROWING DEMAND FOR HTS SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 GROWING ADOPTION OF HTS IN COLLABORATIVE ACADEMIC & RESEARCH ACTIVITIES TO AID MARKET GROWTH
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS
9.5 OTHER END USERS
10 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION (Page No. - 262)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Presence of major research institutes and key pharmaceutical companies to support market growth
10.2.3 CANADA
10.2.3.1 Government initiatives promoting research to support market growth
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing research initiatives to boost market growth
10.3.3 UK
10.3.3.1 Investments by pharmaceutical sponsors for drug discovery to support market
10.3.4 FRANCE
10.3.4.1 Large pharmaceutical R&D expenditure to drive market growth
10.3.5 ITALY
10.3.5.1 Strong collaborative research networks to fuel growth
10.3.6 SPAIN
10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to boost market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 CHINA
10.4.2.1 Growing research and collaborations in field of drug discovery to support growth of market
10.4.3 JAPAN
10.4.3.1 Growing focus on research and strategic collaborations to support market growth
10.4.4 INDIA
10.4.4.1 Developing healthcare industry and ongoing government initiatives to create favorable opportunities for market players
10.4.5 AUSTRALIA
10.4.5.1 Growing pharmaceutical industry to create favorable opportunities for market players
10.4.6 SOUTH KOREA
10.4.6.1 Growing pharmaceutical industry to favor market growth
10.4.7 REST OF ASIA PACIFIC (ROAPAC)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Gradual growth in research to contribute to growth
10.5.3 MEXICO
10.5.3.1 Favorable government support to contribute to growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST
10.6.1 MIDDLE EAST: RECESSION IMPACT
10.6.2 GCC COUNTRIES
10.6.2.1 Saudi Arabia
10.6.2.1.1 Growing pharmaceuticals industry to support market growth
10.6.2.2 UAE
10.6.2.2.1 High R&D expenditure and advanced healthcare infrastructure to boost market growth
10.6.2.3 Rest of GCC Countries
10.7 AFRICA
10.7.1 INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
10.7.2 AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE (Page No. - 404)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Offering footprint
11.5.5.3 Application footprint
11.5.5.4 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES (Page No. - 427)
12.1 KEY PLAYERS
12.1.1 THERMO FISHER SCIENTIFIC INC.
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Deals
12.1.1.3.3 Expansions
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 AGILENT TECHNOLOGIES, INC.
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches & upgrades
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 MERCK KGAA
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Other developments
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 DANAHER CORPORATION
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Product & service launches
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.5 REVVITY, INC.
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.6 TECAN GROUP LTD.
12.1.6.1 Business overview
12.1.6.2 Products & service offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches & upgrades
12.1.6.3.2 Deals
12.1.7 BIO-RAD LABORATORIES, INC.
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.7.3 Recent developments
12.1.7.3.1 Product launches
12.1.8 CORNING INCORPORATED
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches
12.1.9 METTLER-TOLEDO INTERNATIONAL INC.
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.10 LONZA GROUP
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.10.3 Recent developments
12.1.10.3.1 Deals
12.1.11 WATERS CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.11.3 Recent developments
12.1.11.3.1 Product launches
12.1.11.3.2 Deals
12.1.12 SARTORIUS AG
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.13 EPPENDORF SE
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Deals
12.1.13.3.2 Expansions
12.1.14 PORVAIR PLC
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.15 GREINER AG
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.1.16 CHARLES RIVER LABORATORIES
12.1.16.1 Business overview
12.1.16.2 products & services offered
12.1.16.3 Recent developments
12.1.16.3.1 Deals
12.1.17 EUROFINS SCIENTIFIC
12.1.17.1 Business overview
12.1.17.2 Products & services offered
12.1.17.3 Recent developments
12.1.17.3.1 Service launches
12.1.17.3.2 Deals
12.1.17.3.3 Expansions
12.1.18 HAMILTON COMPANY
12.1.18.1 Business overview
12.1.18.2 Products & services offered
12.1.18.3 Recent developments
12.1.18.3.1 Product launches
12.1.18.3.2 Deals
12.1.19 AURORA BIOMED INC.
12.1.19.1 Business overview
12.1.19.2 Products & services offered
12.1.20 GILSON INCORPORATED
12.1.20.1 Business overview
12.1.20.2 Products & services offered
12.1.20.3 Recent developments
12.1.20.3.1 Product launches
12.1.20.3.2 Deals
12.1.21 BRAND GMBH + CO KG
12.1.21.1 Business overview
12.1.21.2 Products & services offered
12.1.21.3 Recent developments
12.1.21.3.1 Expansions
12.2 OTHER PLAYERS
12.2.1 BMG LABTECH GMBH
12.2.2 DIANA BIOTECHNOLOGIES, A.S.
12.2.3 CREATIVE BIOLABS
12.2.4 HIGHRES BIOSOLUTIONS
12.2.5 BIOMAT SRL
12.2.6 AXXAM S.P.A.
12.2.7 SYGNATURE DISCOVERY LIMITED
12.2.8 CROWN BIOSCIENCE
13 APPENDIX (Page No. - 538)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES (731 TABLES)
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 HIGH-THROUGHPUT SCREENING MARKET: IMPACT ANALYSIS
TABLE 3 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, 2023
TABLE 4 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION
TABLE 5 INDICATIVE PRICING FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION, 2021–2023 (USD)
TABLE 6 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS
TABLE 7 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
TABLE 8 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS
TABLE 9 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES
TABLE 10 PATENTS FILED, BY DOCUMENT TYPE, 2012–2023
TABLE 11 INDICATIVE LIST OF PATENTS IN HIGH-THROUGHPUT SCREENING MARKET
TABLE 12 IMPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 IMPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
TABLE 14 IMPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 15 IMPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (UNITS)
TABLE 16 EXPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 17 EXPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
TABLE 18 EXPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 19 EXPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 HIGH-THROUGHPUT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 26 HIGH-THROUGHPUT SCREENING MARKET: LIST OF CONFERENCES & EVENTS
TABLE 27 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 35 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 43 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 50 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 57 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 HIGH-THROUGHPUT SCREENING MARKET FOR FLOW CYTOMETRY INSTRUMENTS FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022–2029 (UNITS)
TABLE 72 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 73 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 80 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 101 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 109 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 116 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 123 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 130 COMPARISON OF 2D AND 3D CELL CULTURES
TABLE 131 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 133 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 140 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 148 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 155 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 163 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 171 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY REGION, 2022–2029 (USD MILLION)
TABLE 179 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY REGION, 2022–2029 (USD MILLION)
TABLE 186 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY REGION, 2022–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2022–2029 (USD MILLION)
TABLE 214 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 222 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 229 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 236 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 243 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 250 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 264 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 266 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 271 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 HIGH-THROUGHPUT SCREENING MARKET (HTS), BY END USER, 2022–2029 (USD MILLION)
TABLE 278 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 279 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 280 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 282 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 285 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 286 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 287 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 288 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 289 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 291 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 293 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 294 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 295 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 296 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 297 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 298 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 299 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 300 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 301 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 302 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 303 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 304 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 305 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 306 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 307 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 308 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 309 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 312 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 313 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 314 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 315 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 319 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 320 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 321 US: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 322 US: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 323 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 324 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 325 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 331 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 332 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 333 CANADA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 334 CANADA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 336 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 339 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 343 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 344 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 345 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 346 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 349 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 EUROPE HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 353 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 355 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 356 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 357 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 358 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 359 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 361 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 363 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 366 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 368 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 369 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 370 UK: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 UK: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 373 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 376 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 379 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 380 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 381 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 382 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 385 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 386 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 392 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 393 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 394 ITALY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 395 ITALY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 396 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 397 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 400 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 404 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 405 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 406 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 409 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 410 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 412 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 413 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 414 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 415 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 416 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 417 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 418 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 419 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 420 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 421 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 422 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 423 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 424 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 425 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 426 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 428 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 429 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 430 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 431 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 432 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 433 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 434 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 435 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 437 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 441 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 442 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 443 CHINA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 CHINA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 445 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 446 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 447 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 450 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 451 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 453 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 454 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 455 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 456 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 457 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 458 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 461 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 463 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 465 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 466 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 467 INDIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 468 INDIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 470 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 471 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 475 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 476 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 477 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 478 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 479 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 480 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 481 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 482 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 483 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 485 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 486 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 487 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 488 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 489 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 490 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 491 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 492 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 493 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 494 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 495 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 496 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 497 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 498 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 499 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 500 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 501 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 502 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 503 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 505 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 506 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 507 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 508 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 509 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 510 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 511 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 512 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 513 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 514 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 515 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 516 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 517 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 518 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 519 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 522 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 523 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 525 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 526 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 527 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 528 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 529 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 531 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 535 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 536 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 537 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 538 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 539 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 540 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 541 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 543 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 545 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 546 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 547 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 548 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 549 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 550 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 551 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 552 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 553 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 554 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 555 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 556 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 557 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 558 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 559 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 560 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 561 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 562 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 563 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 564 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 565 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 566 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 567 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 568 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 569 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 570 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 571 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 572 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 573 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 574 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 575 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 576 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 577 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 578 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 579 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 580 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 581 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 582 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 583 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 584 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 585 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 586 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 587 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 588 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 589 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 590 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 591 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 592 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 593 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 594 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 595 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 596 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 597 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 598 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 599 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 600 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 601 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 602 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 603 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 604 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 605 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 606 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 607 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 608 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 609 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 610 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 611 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 612 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 613 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 614 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 615 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 616 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 617 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 618 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 619 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 620 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 621 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 622 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 623 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 624 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 625 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 626 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 627 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 628 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 629 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 630 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 631 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 632 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 633 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 634 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 635 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 636 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 637 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 638 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 639 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 640 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 641 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 642 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 643 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 644 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 645 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 646 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 647 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 648 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 649 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET
TABLE 650 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEGREE OF COMPETITION
TABLE 651 HIGH-THROUGHPUT SCREENING (HTS) MARKET: OFFERING FOOTPRINT
TABLE 652 HIGH-THROUGHPUT SCREENING (HTS) MARKET: APPLICATION FOOTPRINT
TABLE 653 HIGH-THROUGHPUT SCREENING (HTS) MARKET: REGION FOOTPRINT
TABLE 654 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 655 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 656 HIGH-THROUGHPUT SCREENING (HTS) MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 657 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEALS, JANUARY 2021–MAY 2024
TABLE 658 HIGH-THROUGHPUT SCREENING (HTS) MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 659 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
TABLE 660 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 661 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 662 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 663 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
TABLE 664 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
TABLE 665 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 666 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES
TABLE 667 AGILENT TECHNOLOGIES, INC.: DEALS
TABLE 668 MERCK KGAA: BUSINESS OVERVIEW
TABLE 669 MERCK KGAA: PRODUCTS & SERVICES OFFERED
TABLE 670 MERCK KGAA: OTHER DEVELOPMENTS
TABLE 671 DANAHER CORPORATION: BUSINESS OVERVIEW
TABLE 672 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 673 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES
TABLE 674 DANAHER CORPORATION: DEALS
TABLE 675 DANAHER CORPORATION: EXPANSIONS
TABLE 676 REVVITY, INC.: BUSINESS OVERVIEW
TABLE 677 REVVITY INC.: PRODUCTS & SERVICES OFFERED
TABLE 678 REVVITY, INC.: PRODUCT LAUNCHES
TABLE 679 REVVITY, INC.: DEALS
TABLE 680 TECAN GROUP LTD.: BUSINESS OVERVIEW
TABLE 681 TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED
TABLE 682 TECAN GROUP LTD.: PRODUCT LAUNCHES & UPGRADES
TABLE 683 TECAN GROUP LTD.: DEALS
TABLE 684 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
TABLE 685 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 686 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
TABLE 687 CORNING INCORPORATED: BUSINESS OVERVIEW
TABLE 688 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 689 CORNING INCORPORATED: PRODUCT LAUNCHES
TABLE 690 METTLER-TOLEDO INTERNATIONAL INC.: BUSINESS OVERVIEW
TABLE 691 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
TABLE 692 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCT LAUNCHES
TABLE 693 LONZA GROUP: BUSINESS OVERVIEW
TABLE 694 LONZA GROUP: PRODUCTS & SERVICES OFFERED
TABLE 695 LONZA GROUP: DEALS
TABLE 696 WATERS CORPORATION: BUSINESS OVERVIEW
TABLE 697 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 698 WATERS CORPORATION: PRODUCT LAUNCHES
TABLE 699 WATERS CORPORATION: DEALS
TABLE 700 SARTORIUS AG: BUSINESS OVERVIEW
TABLE 701 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
TABLE 702 SARTORIUS AG: PRODUCT LAUNCHES
TABLE 703 EPPENDORF SE: BUSINESS OVERVIEW
TABLE 704 EPPENDORF SE: PRODUCTS & SERVICES OFFERED
TABLE 705 EPPENDORF SE: DEALS
TABLE 706 EPPENDORF SE: EXPANSIONS
TABLE 707 PORVAIR PLC: BUSINESS OVERVIEW
TABLE 708 PORVAIR PLC: PRODUCTS & SERVICES OFFERED
TABLE 709 GREINER AG: BUSINESS OVERVIEW
TABLE 710 GREINER AG: PRODUCTS & SERVICES OFFERED
TABLE 711 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
TABLE 712 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED
TABLE 713 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS
TABLE 714 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
TABLE 715 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
TABLE 716 EUROFINS SCIENTIFIC: SERVICE LAUNCHES
TABLE 717 EUROFINS SCIENTIFIC: DEALS
TABLE 718 EUROFINS SCIENTIFIC: EXPANSIONS
TABLE 719 HAMILTON COMPANY: BUSINESS OVERVIEW
TABLE 720 HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED
TABLE 721 HAMILTON COMPANY: PRODUCT LAUNCHES
TABLE 722 HAMILTON COMPANY: DEALS
TABLE 723 AURORA BIOMED INC.: BUSINESS OVERVIEW
TABLE 724 AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED
TABLE 725 GILSON INCORPORATED: BUSINESS OVERVIEW
TABLE 726 GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 727 GILSON INCORPORATED.: PRODUCT LAUNCHES
TABLE 728 GILSON INCORPORATED: DEALS
TABLE 729 BRAND GMBH + CO KG: BUSINESS OVERVIEW
TABLE 730 BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED
TABLE 731 BRAND GMBH + CO KG: EXPANSIONS
LIST OF FIGURES (58 FIGURES)
FIGURE 1 HIGH-THROUGHPUT SCREENING (HTS) MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 HIGH-THROUGHPUT SCREENING (HTS) MARKET: BREAKDOWN OF PRIMARIES
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 9 HIGH-THROUGHPUT SCREENING (HTS) MARKET: CAGR PROJECTIONS, 2024–2029
FIGURE 10 HIGH-THROUGHPUT SCREENING (HTS) MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
FIGURE 14 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT: HIGH-THROUGHPUT SCREENING (HTS) MARKET
FIGURE 17 GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH
FIGURE 18 CONSUMABLES DOMINATED NORTH AMERICAN HIGH-THROUGHPUT SCREENING (HTS) MARKET IN 2023
FIGURE 19 CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2029
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN HIGH-THROUGHPUT SCREENING (HTS) MARKET FROM 2024 TO 2029
FIGURE 22 HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR HIGH-THROUGHPUT SCREENING (HTS) SOLUTION PROVIDERS
FIGURE 25 PRICING TREND FOR INSTRUMENTS, 2021–2023
FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING PRODUCT DEVELOPMENT PHASE
FIGURE 27 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
FIGURE 28 ECOSYSTEM ANALYSIS: HIGH-THROUGHPUT SCREENING MARKET
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)
FIGURE 30 HIGH-THROUGHPUT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
FIGURE 32 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
FIGURE 33 ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
FIGURE 36 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 37 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY FOOTPRINT
FIGURE 38 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 39 EV/EBITDA OF KEY VENDORS
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 41 HIGH-THROUGHPUT SCREENING (HTS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46 REVVITY, INC.: COMPANY SNAPSHOT (2023)
FIGURE 47 TECAN GROUP LTD. COMPANY SNAPSHOT (2023)
FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
FIGURE 50 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 LONZA GROUP: COMPANY SNAPSHOT (2023)
FIGURE 52 WATERS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 53 SARTORIUS AG: COMPANY SNAPSHOT (2023)
FIGURE 54 EPPENDORF SE: COMPANY SNAPSHOT (2023)
FIGURE 55 PORVAIR PLC: COMPANY SNAPSHOT (2023)
FIGURE 56 GREINER AG: COMPANY SNAPSHOT (2023)
FIGURE 57 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2023)
FIGURE 58 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
Growth opportunities and latent adjacency in High Throughput Screening Market